Noda AAL, Sabido TL, Galindo GM, Montell HOA, Vidal TLA, Piñeiro AI, Sánchez LC, Abreu ÁH, Noda PA

Language: Spanish
References: 19
Page: 544-551
PDF size: 167.20 Kb.

ABSTRACT

Toxic epidermal necrolysis is the result of severe acute mucocutaneous reaction. The frequency of this disease is higher in the pathological states, when there is "aberrant" immune response including disease, graft against host, cancer, HIV infection and autoimmune diseases. A case that met the diagnostic systemic lupus erythematosus and toxic epidermal necrolysis criteria was described.

REFERENCES

1. Downey A, Jackson C, Harun N, Cooper A. Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol. 2012;66:995-1003.

2. Gerull R, Nelle M, Schaible T. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Crit Care Med. 2011;39(6):1521-32.

3. Morel E, Escamochero S, Caban R, Díaz R, Fiandor A, Ballón T. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Allergy Clin Immunol. 2010;125:703-10.

4. Gulati A, Bagga A. Management of lupus nephritis. Indian Journal of Rheumatology. 2012;7(1) (Suppl):69-79.

5. Sang A, Yin Y, Zheng Y-Y, Morel L. Animal Models of Molecular Pathology: Systemic Lupus Erythematosus. Progress in Molecular Biology and Translational Science. 2012;105:321-70.

6. Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110-21.

7. Lee HY, Tey HL, Pang SM, Thirumoorthy T. Systemic lupus erythematosus presenting as Stevens-Johnson syndrome and toxic epidermal necrolysis: a report of three cases. Lupus. 2011;20(6):647-52

8. Ziemer M, Kardaun SH, Liss Y, Mockenhaupt MB. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature. J Dermatol. 2012;166(3):575-600.

9. Konda S, Fernandez AP, Berman B, Elgart G, Milikowski C, Alonso-Llamazares J. Toxic epidermal necrolysis in the setting of systemic lupus erythematosus. Int J Dermatol. 2011;50(10):1270-5.

10. Mandelcorn R, Shear NH. Lupus-associated toxic epidermal necrolysis: a novel manifestation of lupus? J Am Acad Dermatol. 2003;48(4):525-9.

11. Konda S, Fernandez AP, Berman B, Elgart G, Milikowski C, Alonso-Llamazares J. Toxic epidermal necrolysis in the setting of systemic lupus erythematosus. International Journal of Dermatology. 2011;50:1270-5.

12. Chan HL. Observations on drug-induced toxic epidermal necrolysis in Singapore. J Am Acad Dermatol. 1984;10:973-8.

13. Horne NS, Narayan AR, Young RM, Frieri M. Toxic epidermal necrolysis in systemic lupus erythematosus. Autoimmunity Reviews. 2006;5:160-4.

14. Bielsa I, Herrero C, Font J, Mascaro JM. Lupus erythematosus and toxic epidermal necrolysis [letter]. J Am Acad Dermatol. 1987;16(6):1265-7.

15. Rowell NR, Beck NJ, Anderson JR. Lupus erythematosus and erythema multiforme-like lesions. Arch Dermatol. 1963;88:176-80.

16. Zeitouni NC, Funaro D, Cloutier RA, Gagne E, Claveau J. Redefining Rowell's syndrome. Br J Dermatol. 2000;142:343-6.

17. Vassileva S. Bullous Systemic Lupus Erythematosus. Clinics in Dermatology Y. 2004;22:129-38.

18. Tohyama M, Hashimoto K. Immunological mechanisms of epidermal damage in toxic epidermal necrolysis. Curr Opin Allergy Clin Immunol. 2012;12(4):376-82.

19. Ting W, Stone MS, Racila D, Scofield RH, Sontheimer RD. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic panepidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions. Lupus. 2004;13:941-50.